Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cemex S.A.B. de C.V. Sponsored ADR vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.84B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| CX | RPRX | |
|---|---|---|
Market Cap | $13.84B | $25.27B |
Volume | 6,589,714 | 3,671,183 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $63.96 |
52-Week Low | $9.12 | $35.44 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.83B | $32.50B |
Dividend Yield | 1.3% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cemex S.A.B. de C.V. Sponsored ADR
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
